These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
436 related articles for article (PubMed ID: 24431417)
1. Systematic review on antibiotic therapy for pneumonia in children between 2 and 59 months of age. Lassi ZS; Das JK; Haider SW; Salam RA; Qazi SA; Bhutta ZA Arch Dis Child; 2014 Jul; 99(7):687-93. PubMed ID: 24431417 [TBL] [Abstract][Full Text] [Related]
2. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. Lassi ZS; Imdad A; Bhutta ZA Cochrane Database Syst Rev; 2015 Jun; (6):CD008032. PubMed ID: 26077639 [TBL] [Abstract][Full Text] [Related]
3. Short-course versus long-course antibiotic therapy for non-severe community-acquired pneumonia in children aged 2 months to 59 months. Haider BA; Saeed MA; Bhutta ZA Cochrane Database Syst Rev; 2008 Apr; (2):CD005976. PubMed ID: 18425930 [TBL] [Abstract][Full Text] [Related]
6. Oral antibiotics versus parenteral antibiotics for severe pneumonia in children. Rojas MX; Granados C Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD004979. PubMed ID: 16625618 [TBL] [Abstract][Full Text] [Related]
7. Short-course versus long-course intravenous therapy with the same antibiotic for severe community-acquired pneumonia in children aged two months to 59 months. Lassi ZS; Imdad A; Bhutta ZA Cochrane Database Syst Rev; 2017 Oct; 10(10):CD008032. PubMed ID: 29020436 [TBL] [Abstract][Full Text] [Related]
8. Shorter versus longer duration of Amoxicillin-based treatment for pediatric patients with community-acquired pneumonia: a systematic review and meta-analysis. R Marques I; P Calvi I; A Cruz S; M F Sanchez L; F Baroni I; Oommen C; H Padrao EM; C Mari P Eur J Pediatr; 2022 Nov; 181(11):3795-3804. PubMed ID: 36066660 [TBL] [Abstract][Full Text] [Related]
10. Antibiotic therapy versus no antibiotic therapy for children aged two to 59 months with WHO-defined non-severe pneumonia and wheeze. Lassi ZS; Kumar R; Das JK; Salam RA; Bhutta ZA Cochrane Database Syst Rev; 2014 May; (5):CD009576. PubMed ID: 24859388 [TBL] [Abstract][Full Text] [Related]
11. A clinical and economic study of community-acquired pneumonia between single versus combination therapy. Hasali MA; Ibrahim MI; Sulaiman SA; Ahmad Z; Hasali JB Pharm World Sci; 2005 Jun; 27(3):249-53. PubMed ID: 16096896 [TBL] [Abstract][Full Text] [Related]
12. Antibiotic treatment for children hospitalized with community-acquired pneumonia after oral therapy. Breuer O; Blich O; Cohen-Cymberknoh M; Averbuch D; Kharasch S; Shoseyov D; Kerem E Pediatr Pulmonol; 2015 May; 50(5):495-502. PubMed ID: 25652187 [TBL] [Abstract][Full Text] [Related]
13. Ambulatory short-course high-dose oral amoxicillin for treatment of severe pneumonia in children: a randomised equivalency trial. Hazir T; Fox LM; Nisar YB; Fox MP; Ashraf YP; MacLeod WB; Ramzan A; Maqbool S; Masood T; Hussain W; Murtaza A; Khawar N; Tariq P; Asghar R; Simon JL; Thea DM; Qazi SA; Lancet; 2008 Jan; 371(9606):49-56. PubMed ID: 18177775 [TBL] [Abstract][Full Text] [Related]
14. Antibiotics for community acquired pneumonia in adult outpatients. Bjerre LM; Verheij TJ; Kochen MM Cochrane Database Syst Rev; 2004; (2):CD002109. PubMed ID: 15106168 [TBL] [Abstract][Full Text] [Related]
15. Pharmacotherapy of childhood pneumonia. Nascimento-Carvalho CM Expert Opin Pharmacother; 2010 Feb; 11(2):225-31. PubMed ID: 20088744 [TBL] [Abstract][Full Text] [Related]
16. Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial. Bielicki JA; Stöhr W; Barratt S; Dunn D; Naufal N; Roland D; Sturgeon K; Finn A; Rodriguez-Ruiz JP; Malhotra-Kumar S; Powell C; Faust SN; Alcock AE; Hall D; Robinson G; Hawcutt DB; Lyttle MD; Gibb DM; Sharland M; JAMA; 2021 Nov; 326(17):1713-1724. PubMed ID: 34726708 [TBL] [Abstract][Full Text] [Related]
17. Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review. Mathur S; Fuchs A; Bielicki J; Van Den Anker J; Sharland M Paediatr Int Child Health; 2018 Nov; 38(sup1):S66-S75. PubMed ID: 29790844 [TBL] [Abstract][Full Text] [Related]
18. An update on antimicrobial options for childhood community-acquired pneumonia: a critical appraisal of available evidence. Nascimento-Carvalho CM; Andrade DC; Vilas-Boas AL Expert Opin Pharmacother; 2016; 17(1):53-78. PubMed ID: 26549167 [TBL] [Abstract][Full Text] [Related]
19. Oral Antibiotics for Community acquired Pneumonia with Chest indrawing in Children Aged Below Five Years: A Systematic Review. Lodha R; Randev S; Kabra SK Indian Pediatr; 2016 Jun; 53(6):489-95. PubMed ID: 27376603 [TBL] [Abstract][Full Text] [Related]
20. Short-Course vs Long-Course Antibiotic Therapy for Children With Nonsevere Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Li Q; Zhou Q; Florez ID; Mathew JL; Shang L; Zhang G; Tian X; Fu Z; Liu E; Luo Z; Chen Y JAMA Pediatr; 2022 Dec; 176(12):1199-1207. PubMed ID: 36374480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]